Suvizumab
Suvizumab is an antiviral and immunomodulator. It binds to HIV-1.[1]
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody | 
| Source | Humanized | 
| Target | HIV-1 | 
| Clinical data | |
| ATC code | 
 | 
| Identifiers | |
| CAS Number | |
| ChemSpider | 
 | 
| UNII | |
|   (what is this?)  (verify) | |
References
    
- "Proposed List number 102 of International Nonproprietary Names" (PDF). WHO Drug Information. Geneva: World Health Organization. 23 (4): 344. 2009. ISSN 1010-9609.
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.